Should You Buy BioNTech SE - ADR (BNTX) Stock Friday Morning?

BioNTech SE - ADR (BNTX) is lower by Friday morning, with the stock losing -2.17% in pre-market trading to 153.52. BNTX's short-term technical score of 44 indicates that the stock has traded less bullishly over the last month than 56% of stocks on the market. In the Biotechnology industry, which ranks 96 out of 146 industries, BioNTech SE - ADR ranks higher than 45% of stocks. BioNTech SE - ADR has risen 21.18% over the past month, closing at $135.62 on October 14. During this period of time, the stock fell as low as $118.43 and as high as $163.34. BNTX has an average analyst recommendation of Buy. The company has an average price target of $216.00.

BNTX has an Overall Score of 44. Find out what this means to you and get the rest of the rankings on BNTX!

See Full BNTX Report

BioNTech SE - ADR has a Long-Term Technical rank of 51. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 49% of the market scoring higher. In the Biotechnology industry which is number 117 by this metric, BNTX ranks better than 117% of stocks.

Important Dates for Investors in BNTX:

-BioNTech SE - ADR is set to release earnings on 2/5/2023. Over the last 12 months, the company has reported EPS of $41.29. -We do not have a set dividend date for BioNTech SE - ADR at this time. Click Here To Get The Full Report on BioNTech SE - ADR (BNTX)